NAMPT and neoplasm: The short-term treatment with NAMPT inhibitors, including multitarget NAMPT inhibitors or NAMPTi-ADCs, displayed marked antineoplastic efficacy across a wide spectrum of tumor murine models, either as single-agent therapy or in combination with other anticancer treatments.